Building a Secure and Ethical Biodata Infrastructure: Challenges and Opportunities

The U.S. bioeconomy already accounts for about 5% of the country’s gross domestic product ($960 billion) and is rapidly expanding. Biomanufacturing is becoming a major mode of production for a wide range of industries, from pharmaceuticals and industrial chemicals to food and fuels. Biotechnologies can also play important roles in ensuring supply chain resiliency, mitigating…

IDST Monthly Access Membership Required

You must be a IDST Monthly Access member to access this content.

IDST Pro Access Required

This analysis is part of IDST premium intelligence.

Subscribe to Continue Reading